DHSC, NHSE&I and PHE will continue to face significant challenges in making sure they can get the vaccine to the right people at the right time. Each vaccine will require different plans for deploying because each has different characteristics. Getting the vaccine to the right place to allow it to be administered is challenging. For example, the Pfizer Inc and BioNTech SE vaccine must be stored at -70°c, whereas the vaccine developed by the Astra-Zeneca Ltd—University of Oxford partnership ca...

DHSC, NHSE&I and PHE will continue to face significant challenges in making sure they can get the vaccine to the right people at the right time. Each vaccine will require different plans for deploying because each has different characteristics. Getting the vaccine to the right place to allow it to be administered is challenging. For example, the Pfizer Inc and BioNTech SE vaccine must be stored at -70°c, whereas the vaccine developed by the Astra-Zeneca Ltd—University of Oxford partnership can be stored at between 2°c and minus 8°c. BEIS considered the logistics of deployment as part of deciding which vaccines to purchase but prioritised whet Type: conclusion | Number: 4 | Response status: under_consideration Government response: 5. PAC conclusion: HM Treasury breached its Capital Annually Managed Expenditure total by £32 million. 2 4